The Union Health Ministry said on Friday that the COVID-19
The vaccine will be safe and effective, but it could show minor side effects, such as fever and pain at the injection site, and the injection will be voluntary.
The comment comes at a time when questions are being raised about the safety and efficacy of the vaccine that is being developed at a phenomenal rate. According to a recent survey, almost 70 percent of people hesitate to take the vaccine for fear of its side effects.
To assuage fear, the Health Ministry said: “Covid-19 vaccines will be introduced only when their safety is proven. The vaccines will be safe and effective, but may have minor side effects such as fever, pain, etc. at the site of the injection. These effects can occur in any vaccine. “
States have been ordered to start making arrangements to deal with COVID-19 Side effects related to the vaccine as one of the measures for the safe delivery of the vaccine among the masses, the ministry said in a statement.
The ministry clarified this in a series of frequently asked questions about COVID-19 vaccine and answered questions such as is the vaccine scheduled in the short term, how long does it take for antibodies to develop, and whether it was necessary for a recovered person to take the vaccine?
Recently, Health Secretary Rajesh Bhushan said that “adverse” reactions cannot be ruled out when vaccination begins. Such events have also been seen in some cases with Pfizer-Biontech’s Covid vaccine in the UK.
The UK government had asked people with a significant history of allergies not to get vaccinated.
In a sign of relief, vaccinated individuals will be monitored for thirty minutes to receive vaccinations for any adverse events, in accordance with recently released guidelines for the mass vaccination campaign.
In addition to this, the ministry said that getting vaccinated against COVID-19 it will be voluntary, while underlining that the vaccine introduced in India will be as effective as any vaccine developed by other countries.
He further stated that it was advisable to receive a full schedule of the coronavirus vaccine regardless of the history of infection by COVID-19 as this will help develop a strong immune response against the disease.
Up to eight COVID-19 Vaccine candidates are in different stages of clinical trials that could be ready for authorization in the near future, including three indigenous vaccines.
Includes AstraZeneca and the University of Oxford and Covishield manufactured by the Serum Institute of India; Covaxin from Bharat Biotech Limited; ZyCoV-D from Zydus Cadila and the Russian vaccine candidate Sputnik-V.
The list also contains NVX-CoV2373 from IBS, HGCO19 from Geneva and two unlabeled vaccines: recombinant protein antigen-based vaccine from Biological E Limited; and inactivated rabies vector platform from Bharat Biotech.
In the FAQ, the ministry stated that vaccine trials are in different stages of completion. The government is prepared to launch a vaccine soon.
.
